Andrew E. Tee

1.5k total citations
18 papers, 909 citations indexed

About

Andrew E. Tee is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Andrew E. Tee has authored 18 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Neurology and 9 papers in Cancer Research. Recurrent topics in Andrew E. Tee's work include Neuroblastoma Research and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Protein Degradation and Inhibitors (6 papers). Andrew E. Tee is often cited by papers focused on Neuroblastoma Research and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Protein Degradation and Inhibitors (6 papers). Andrew E. Tee collaborates with scholars based in Australia, United States and China. Andrew E. Tee's co-authors include Tao Liu, Glenn M. Marshall, Pei Y. Liu, Murray D. Norris, Michelle Haber, Bernard Atmadibrata, Bing Liu, Belamy B. Cheung, Matthew Wong and Marcel E. Dinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Andrew E. Tee

18 papers receiving 902 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Andrew E. Tee 746 373 179 133 89 18 909
Marli E. Ebus 452 0.6× 162 0.4× 317 1.8× 243 1.8× 82 0.9× 14 681
Yasumichi Kuwahara 472 0.6× 124 0.3× 119 0.7× 131 1.0× 119 1.3× 42 687
Mark W. Zimmerman 530 0.7× 170 0.5× 319 1.8× 121 0.9× 47 0.5× 24 706
Samuele Gherardi 538 0.7× 184 0.5× 287 1.6× 176 1.3× 20 0.2× 20 730
Olesya Chayka 378 0.5× 129 0.3× 159 0.9× 210 1.6× 45 0.5× 17 571
John M. Krill-Burger 504 0.7× 118 0.3× 70 0.4× 88 0.7× 61 0.7× 14 679
Katia Balmas Bourloud 532 0.7× 175 0.5× 284 1.6× 221 1.7× 34 0.4× 19 719
Kristina Althoff 547 0.7× 197 0.5× 256 1.4× 154 1.2× 32 0.4× 21 727
JulieAnn Rader 304 0.4× 136 0.4× 140 0.8× 259 1.9× 165 1.9× 8 542

Countries citing papers authored by Andrew E. Tee

Since Specialization
Citations

This map shows the geographic impact of Andrew E. Tee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Tee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Tee more than expected).

Fields of papers citing papers by Andrew E. Tee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew E. Tee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Tee. The network helps show where Andrew E. Tee may publish in the future.

Co-authorship network of co-authors of Andrew E. Tee

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew E. Tee. A scholar is included among the top collaborators of Andrew E. Tee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew E. Tee. Andrew E. Tee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hulme, Amy E., Andrew E. Tee, Jane Sun, et al.. (2021). The RNA‐helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma. Molecular Oncology. 15(4). 1162–1179. 20 indexed citations
2.
Tee, Andrew E., Matthew Wong, Jamie I. Fletcher, et al.. (2020). Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN‐amplified neuroblastoma. International Journal of Cancer. 147(7). 1928–1938. 27 indexed citations
3.
Bi, Ling, Chanlu Xie, Yao Mu, et al.. (2018). The histone chaperone complex FACT promotes proliferative switch of G0 cancer cells. International Journal of Cancer. 145(1). 164–178. 23 indexed citations
4.
Wong, Matthew, Andrew E. Tee, Giorgio Milazzo, et al.. (2017). The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. Cancer Research. 77(9). 2522–2533. 53 indexed citations
5.
Sun, Yuting, Bernard Atmadibrata, Denise Yu, et al.. (2017). Upregulation of LYAR induces neuroblastoma cell proliferation and survival. Cell Death and Differentiation. 24(9). 1645–1654. 16 indexed citations
6.
Liu, Pei Y., et al.. (2016). NCYM is upregulated by lncUSMycN and modulates N-Myc expression. International Journal of Oncology. 49(6). 2464–2470. 19 indexed citations
7.
Tee, Andrew E., Pei Y. Liu, Giorgio Milazzo, et al.. (2016). Abstract 2664: Eradication of neuroblastoma by suppressing the expression of a single long noncoding RNA. Cancer Research. 76(14_Supplement). 2664–2664. 1 indexed citations
8.
Tee, Andrew E., Peiyan Liu, Jesper L.V. Mååg, et al.. (2015). Abstract 146: The long noncoding RNA MALAT1 promotes hypoxia-driven angiogenesis by upregulating pro-angiogenic gene expression in neuroblastoma cells. Cancer Research. 75(15_Supplement). 146–146. 2 indexed citations
9.
Tee, Andrew E., Bing Liu, Renhua Song, et al.. (2015). The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression. Oncotarget. 7(8). 8663–8675. 92 indexed citations
10.
Liu, Pei Y., Glenn M. Marshall, Andrew E. Tee, et al.. (2014). Effects of a Novel Long Noncoding RNA, lncUSMycN, on N-Myc Expression and Neuroblastoma Progression. JNCI Journal of the National Cancer Institute. 106(7). 89 indexed citations
11.
Atmadibrata, Bernard, Pei Y. Liu, Lihong Zhang, et al.. (2014). The Novel Long Noncoding RNA linc00467 Promotes Cell Survival but Is Down-Regulated by N-Myc. PLoS ONE. 9(2). e88112–e88112. 59 indexed citations
12.
Tee, Andrew E., Dora Ling, Charlotte Nelson, et al.. (2014). The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget. 5(7). 1793–1804. 97 indexed citations
13.
Shahbazi, Jeyran, Christopher J. Scarlett, Murray D. Norris, et al.. (2014). Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1. Oncotarget. 5(12). 4257–4268. 22 indexed citations
14.
Liu, Tao, Pei Y. Liu, Andrew E. Tee, et al.. (2009). Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors. European Journal of Cancer. 45(10). 1846–1854. 33 indexed citations
15.
Tee, Andrew E., Glenn M. Marshall, Pei Y. Liu, et al.. (2009). Opposing Effects of Two Tissue Transglutaminase Protein Isoforms in Neuroblastoma Cell Differentiation. Journal of Biological Chemistry. 285(6). 3561–3567. 44 indexed citations
16.
Liu, Tao, Andrew E. Tee, Michelle Haber, et al.. (2007). Enhancing the anti-angiogenic action of histone deacetylase inhibitors. Molecular Cancer. 6(1). 68–68. 25 indexed citations
17.
Liu, Tao, Andrew E. Tee, Antônio Porro, et al.. (2007). Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proceedings of the National Academy of Sciences. 104(47). 18682–18687. 88 indexed citations
18.
Liu, Tao, et al.. (2006). Histone deacetylase inhibitors: Multifunctional anticancer agents. Cancer Treatment Reviews. 32(3). 157–165. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marli E. Ebus Breakdown of academic impact, for papers by Yasumichi Kuwahara Breakdown of academic impact, for papers by Mark W. Zimmerman Breakdown of academic impact, for papers by Samuele Gherardi Breakdown of academic impact, for papers by Olesya Chayka Breakdown of academic impact, for papers by John M. Krill-Burger Breakdown of academic impact, for papers by Katia Balmas Bourloud Breakdown of academic impact, for papers by Kristina Althoff Breakdown of academic impact, for papers by JulieAnn Rader
Rankless by CCL
2026